These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36289074)

  • 1. Postmortem PF4 antibodies confirm a rare case of thrombosis thrombocytopenia syndrome associated with ChAdOx1 nCoV-19 anti-COVID vaccination.
    Alunni V; Bernardi C; Chevalier N; Cabusat C; Quatrehomme G; Torrents J; Biglia E; Gaillard Y; Drici MD
    Int J Legal Med; 2023 Mar; 137(2):487-492. PubMed ID: 36289074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.
    Greinacher A; Thiele T; Warkentin TE; Weisser K; Kyrle PA; Eichinger S
    N Engl J Med; 2021 Jun; 384(22):2092-2101. PubMed ID: 33835769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low clinical utility of testing for anti-platelet factor 4 in asymptomatic individuals after ChAdOx1 nCoV-19 vaccine.
    Barefah AS; Radhwi OO; Alamri SS; Alahwal HM; Denetiu I; Almohammadi AT; Bahashwan SM; Qari MH; Algaissi A; Alamer E; Alhazmi A; Abuzenadah AM; Nasraldeen WH; Alzahrani SH; Hashem AM
    Int J Lab Hematol; 2022 Apr; 44(2):424-429. PubMed ID: 34850575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracerebral Hemorrhage due to Thrombosis with Thrombocytopenia Syndrome after Vaccination against COVID-19: the First Fatal Case in Korea.
    Choi JK; Kim S; Kim SR; Jin JY; Choi SW; Kim H; Yoo JH; Park IS; Kim SR
    J Korean Med Sci; 2021 Aug; 36(31):e223. PubMed ID: 34402235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of anti-platelet factor4/polyanionic antibodies, thrombocytopenia, and thrombosis after COVID-19 vaccination with ChAdOx1 nCoV-19 in Thais.
    Boonyawat K; Phojanasenee T; Noikongdee P; Police P; Chantrathammachart P; Niparuck P; Puavilai T; Phuphuakrat A; Angchaisuksiri P
    Thromb J; 2023 Sep; 21(1):92. PubMed ID: 37674185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of anti-platelet factor 4 antibodies and platelet activation tests in patients with vaccine-induced immune thrombotic thrombocytopenia: Brief report on a comparison of the laboratory diagnosis and literature review.
    Hsiao PJ; Wu KL; Chen YC; Chen YL; Wang RL; Wu KA; Chan JS; Chiu CC; Huang LY; Shyu HY; Kao YH; Chuu CP
    Clin Chim Acta; 2022 Apr; 529():42-45. PubMed ID: 35167842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral venous sinus thrombosis after ChAdOx1 vaccination: the first case of definite thrombosis with thrombocytopenia syndrome from India.
    Maramattom BV; Moidu FM; Varikkottil S; Syed AA
    BMJ Case Rep; 2021 Oct; 14(10):. PubMed ID: 34706921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of positive anti-PF4/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2.
    Thiele T; Ulm L; Holtfreter S; Schönborn L; Kuhn SO; Scheer C; Warkentin TE; Bröker BM; Becker K; Aurich K; Selleng K; Hübner NO; Greinacher A
    Blood; 2021 Jul; 138(4):299-303. PubMed ID: 33988688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review.
    Sharifian-Dorche M; Bahmanyar M; Sharifian-Dorche A; Mohammadi P; Nomovi M; Mowla A
    J Neurol Sci; 2021 Sep; 428():117607. PubMed ID: 34365148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aortic thrombosis and acute limb ischemia after ChAdOx1 nCov-19 (Oxford-AstraZeneca) vaccination: a case of vaccine-induced thrombocytopenia and thrombosis (VITT).
    Vierstraete M; Sabbe T
    Acta Chir Belg; 2023 Jun; 123(3):329-332. PubMed ID: 34890294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral venous sinus thrombosis after adenovirus-vectored COVID-19 vaccination: review of the neurological-neuroradiological procedure.
    Wittstock M; Walter U; Volmer E; Storch A; Weber MA; Großmann A
    Neuroradiology; 2022 May; 64(5):865-874. PubMed ID: 35184205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine associated benign headache and cutaneous hemorrhage after ChAdOx1 nCoV-19 vaccine: A cohort study.
    Schultz NH; Søraas AVL; Sørvoll IH; Akkök ÇA; Vetlesen A; Bhamra JS; Ahlen MT; Holme PA; Aamodt AH; Skagen K; Skattør TH; Skjelland M; Wiedmann MK
    J Stroke Cerebrovasc Dis; 2023 Jan; 32(1):106860. PubMed ID: 36403363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential mechanisms of vaccine-induced thrombosis.
    Marietta M; Coluccio V; Luppi M
    Eur J Intern Med; 2022 Nov; 105():1-7. PubMed ID: 35953336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical care pathway for the evaluation of patients with suspected VITT after ChAdOx1 nCoV-19 vaccination.
    Lee AYY; Al Moosawi M; Peterson EA; McCracken RK; Wong SKW; Nicolson H; Chan V; Smith T; Wong MP; Lee LJ; Griffiths C; Rahal B; Parkin S; Afra K; Ambler K; Chen LYC; Field TS; Lindsay HC; Lavoie M; Li C; Migneault D; Naus M; Piszczek J; Rahmani P; Sreenivasan G; Wan T; Yee A; Zypchen L; Sweet D
    Blood Adv; 2022 Jun; 6(11):3315-3320. PubMed ID: 35201292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ChAdOx1 nCoV-19 Vaccine and Thrombosis with Thrombocytopenia Syndrome among Adults: A Systematic Review.
    Faghihi H; Mottaghi-Dastjerdi N; Sharifzadeh M; Rahimi Kakavandi N
    Adv Pharm Bull; 2023 Nov; 13(4):723-735. PubMed ID: 38022808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An observational study to identify the prevalence of thrombocytopenia and anti-PF4/polyanion antibodies in Norwegian health care workers after COVID-19 vaccination.
    Sørvoll IH; Horvei KD; Ernstsen SL; Laegreid IJ; Lund S; Grønli RH; Olsen MK; Jacobsen HK; Eriksson A; Halstensen AM; Tjønnfjord E; Ghanima W; Ahlen MT
    J Thromb Haemost; 2021 Jul; 19(7):1813-1818. PubMed ID: 33909350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncommon thrombotic complications after SARS-CoV-2 vaccination.
    Musil D
    Vnitr Lek; 2021; 67(5):297-302. PubMed ID: 35459396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of Ad26.COV2.S-associated vaccine-induced immune thrombotic thrombocytopenia (VITT) and specific detection of VITT antibodies.
    Kanack AJ; Singh B; George G; Gundabolu K; Koepsell SA; Abou-Ismail MY; Moser KA; Smock KJ; Green D; Major A; Chan CW; Wool GD; Reding M; Ashrani AA; Bayas A; Grill DE; Padmanabhan A
    Am J Hematol; 2022 May; 97(5):519-526. PubMed ID: 35132672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal intracerebral haemorrhage associated with thrombosis with thrombocytopenia syndrome after ChAdOx1-S vaccine.
    Gómez-Roldós A; González-Sánchez M; Vales-Montero M; Vázquez-Alen P; Fernández-Bullido Y; Iglesias-Mohedano AM; Díaz-Otero F; García-Pastor A; Gil-Núñez A
    Rev Neurol; 2022 Oct; 75(7):199-202. PubMed ID: 36169326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective review COVID-19 vaccine induced thrombotic thrombocytopenia and cerebral venous thrombosis-what can we learn from the immune response.
    Franceschi AM; Petrover DR; McMahon TM; Libman RB; Giliberto L; Clouston SAP; Castillo M; Kirsch C
    Clin Imaging; 2022 Oct; 90():63-70. PubMed ID: 35926315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.